{"id":"W4407288611","doi":"10.1136/jitc-2024-009890","title":"Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry","year":2025,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"Iovance Biotherapeutics; Janssen Research and Development; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; bluebird bio; Pharmacyclics; Takeda Oncology; Legend Biotech; U.S. Navy; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; CytoSen Therapeutics; MorphoSys; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; CSL Behring; Kyowa Kirin Pharmaceutical Development; Atara Biotherapeutics; Vertex Pharmaceuticals; Anthem Foundation; GlaxoSmithKline; Kiadis Pharma; Sanofi; TG Therapeutics; Medac; Jazz Pharmaceuticals; Omeros Corporation; U.S. Department of Defense; Medical College of Wisconsin; StemCyte; AbbVie; Actinium Pharmaceuticals; Gilead Sciences; Stanford University; National Marrow Donor Program; Mallinckrodt Pharmaceuticals; Merck; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma US; Be The Match Foundation; Novartis Pharmaceuticals Corporation; Dana-Farber Cancer Institute; Allogene Therapeutics; Incyte; Pfizer; Amgen; Boston Children's Hospital; HistoGenetics","keywords":"Medicine; Cytokine release syndrome; Fludarabine; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Diffuse large B-cell lymphoma; Salvage therapy; Cohort; Lymphoma; Transplantation; Chimeric antigen receptor; Immunotherapy; Chemotherapy; Cancer; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004930022,0.0002520793,0.0007234198,0.000337913,0.0001725857,0.00007066092,0.0004312576,0.00009986465,0.001110028],"category_scores_gemma":[0.00005476067,0.0001458113,0.0003752538,0.0006981635,0.0002211464,0.00009919552,0.00002901067,0.0003997311,0.00000141333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000584026,"about_ca_system_score_gemma":0.0009968546,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00728215,"about_ca_topic_score_gemma":0.004110081,"domain_scores_codex":[0.9980328,0.0001158144,0.000626729,0.0002644817,0.0005635874,0.000396562],"domain_scores_gemma":[0.9977378,0.0006657884,0.0006060873,0.0005993374,0.0003173288,0.00007366877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01965703,0.0008800381,0.3487561,0.0001423562,0.003442056,0.0001315055,0.001359666,0.000123369,0.4467829,0.00008869085,0.01419347,0.1644428],"study_design_scores_gemma":[0.04058722,0.0007702164,0.6797974,0.001976591,0.0004417945,0.0000371867,0.0010664,0.000140965,0.1752793,0.001307728,0.09821535,0.0003799297],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626716,0.02571472,0.0002495477,0.005086837,0.0004473518,0.0008072791,0.00006387069,0.00001776602,0.00494098],"genre_scores_gemma":[0.864639,0.03130359,0.001236,0.002271249,0.0004443864,0.0002138238,0.00001971863,0.0001066883,0.09976552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3310412,"threshold_uncertainty_score":0.9998031,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04027750660366552,"score_gpt":0.41093005155627,"score_spread":0.3706525449526045,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}